Search Results - "Mass, Michele K."

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study by Solomon, Andrew J, Bourdette, Dennis N, Cross, Anne H, Applebee, Angela, Skidd, Philip M, Howard, Diantha B, Spain, Rebecca I, Cameron, Michelle H, Kim, Edward, Mass, Michele K, Yadav, Vijayshree, Whitham, Ruth H, Longbrake, Erin E, Naismith, Robert T, Wu, Gregory F, Parks, Becky J, Wingerchuk, Dean M, Rabin, Brian L, Toledano, Michel, Tobin, W Oliver, Kantarci, Orhun H, Carter, Jonathan L, Keegan, B Mark, Weinshenker, Brian G

“…OBJECTIVE:To characterize patients misdiagnosed with multiple sclerosis (MS). METHODS:Neurologists at 4 academic MS centers submitted data on patients…”
Get full text

Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis by Herndon, Robert M, Rudick, Richard A, Munschauer, Frederick E, Mass, Michele K, Salazar, Andres M, Coats, Michael E, Labutta, Robert, Richert, John R, Cohan, Stanley L, Genain, Claude, Goodkin, Donald, Toal, Martin, Riester, Katherine

“…An open-label extension study of the phase III trial of intramuscular interferon beta-1a (IFNβ-1a-Avonex) was conducted to evaluate the immunogenicity and…”
Get full text

Factors that predict health-related Quality of Life in patients with relapsing-remitting multiple sclerosis by MILLER, Deborah M, RUDICK, Richard A, BAIER, Monika, CUTTER, Gary, DOUGHTERY, David S, WEINSTOCK-GUTTMAN, Bianca, MASS, Michele K, FISHER, Elizabeth, SIMONIAN, Nancy

“…Health-Related Quality of Life (HRQoL) research is gaining acceptance in the field of multiple sclerosis (MS). Little is known about what precipitates quality…”
Get full text

Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis by Rudick, Richard A., Cookfair, Diane L., Simonian, Nancy A., Ransohoff, Richard M., Richert, John R., Jacobs, Lawrence D., Herndon, Robert M., Salazar, Andres M., Fischer, Jill S., Granger, Carl V., Goodkin, Donald E., Simon, Jack H., Bartoszak, David M., Bourdette, Dennis N., Braiman, Jonathan, Brownscheidle, Carol M., Coats, Michael E., Cohan, Stanley L., Dougherty, David S., Kinkel, Revere P., Mass, Michele K., Munchsauer, Frederick E., O'Reilly, Kathy, Priore, Roger L., Pullicino, Patrick M., Scherokman, Barbara J., Wende, Karl, Weinstock-Guttman, Bianca, Whitham, Ruth H.

“…Background and objective: This report provides results of CSF analyses done in a subset of relapsing remitting MS patients participating in a…”
Get full text

Eight-year immunogenicity and safety of interferon beta-la-avonex® treatment in patients with multiple sclerosis by HERNDON, Robert M, RUDICK, Richard A, GOODKIN, Donald, TOAL, Martin, RIESTER, Katherine, MUNSCHAUER, Frederick E, MASS, Michele K, SALAZAR, Andres M, COATS, Michael E, LABUTTA, Robert, RICHERT, John R, COHAN, Stanley L, GENAIN, Claude

Get full text

Factors that predict Health-Related Q uality of Life in patients with relapsing -remitting multiple sclerosis by Miller, Deborah M, Rudick, Richard A, Baier, Monika, Cutter, Gary, Doughtery, David S, Weinstock-Guttman, Bianca, Mass, Michele K, Fisher, Elizabeth, Simonian, Nancy

“…Health-Related Q uality of Life (HRQ oL) research is gaining acceptance in the field of multiple sclerosis (MS). Little is known about what precipitates…”
Get full text

Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis1Studies supported by the National Multiple Sclerosis Society (grants RG2019, RG2827); the NINDS (NS26321); and Biogen Inc.1 by Rudick, Richard A., Cookfair, Diane L., Simonian, Nancy A., Ransohoff, Richard M., Richert, John R., Jacobs, Lawrence D., Herndon, Robert M., Salazar, Andres M., Fischer, Jill S., Granger, Carl V., Goodkin, Donald E., Simon, Jack H., Bartoszak, David M., Bourdette, Dennis N., Braiman, Jonathan, Brownscheidle, Carol M., Coats, Michael E., Cohan, Stanley L., Dougherty, David S., Kinkel, Revere P., Mass, Michele K., Munchsauer, Frederick E., O'Reilly, Kathy, Priore, Roger L., Pullicino, Patrick M., Scherokman, Barbara J., Wende, Karl, Weinstock-Guttman, Bianca, Whitham, Ruth H.

Get full text

Myelination of axons within cytosine arabinoside treated mouse cerebellar explants by cultured rat oligodendrocytes by Seil, F J, Johnson, M L, Saneto, R P, Herndon, R M, Mass, M K

“…Cell suspensions of cultured purified rat oligodendrocytes prepared by the differential substrate adhesion method were applied to neonatal mouse cerebellar…”
Get more information